DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-2.56%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.41B
AUM Growth
+$2.41B
(+12%)
Cap. Flow
+$318M
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
37.73%
Holding
113
New
19
Increased
14
Reduced
20
Closed
12
Top Buys
| 1 |
Elevance Health
ELV
|
$45.7M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$45.6M |
| 3 |
LCI
Lannett Company, Inc.
LCI
|
$44.3M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$40.8M |
| 5 |
Centene
CNC
|
$34.1M |
Top Sells
| 1 |
DaVita
DVA
|
$23.1M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$22.1M |
| 3 |
Select Medical
SEM
|
$18.3M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$17.5M |
| 5 |
AET
Aetna Inc
AET
|
$15.4M |
Sector Composition
| 1 | Healthcare | 69.82% |
| 2 | Financials | 2.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
26
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $22M | 0.91% |
1,812,778
| – | – |
|
27
Ascendis Pharma
ASND
$12.2B
| $21.3M | 0.87% |
+1,050,000
| New | +$21.3M |
|
28
BioCryst Pharmaceuticals
BCRX
$1.7B
| $20.5M | 0.84% |
3,237,734
-1,164,112
| -26% | -$7.37M |
|
|
MNK
29
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $20.3M | 0.83% |
+407,000
| New | +$20.3M |
|
|
EPZM
30
DELISTED
Epizyme, Inc
EPZM
| $19.4M | 0.8% |
1,601,049
+1,309,870
| +450% | +$15.8M |
|
|
BLUE
31
DELISTED
bluebird bio
BLUE
| $18.6M | 0.77% |
302,027
+78,027
| +35% | +$4.81M |
|
|
MYOV
32
DELISTED
Myovant Sciences Ltd.
MYOV
| $18.6M | 0.77% |
+1,496,675
| New | +$18.6M |
|
|
SCTL
33
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $16.7M | 0.69% |
+2,075,000
| New | +$16.7M |
|
34
Axogen
AXGN
$710M
| $16.5M | 0.68% |
1,838,225
-54,805
| -3% | -$493K |
|
35
Zimmer Biomet
ZBH
$20.6B
| $15.5M | 0.64% |
+150,000
| New | +$15.5M |
|
|
TSRO
36
DELISTED
TESARO, Inc.
TSRO
| $15.1M | 0.62% |
112,200
-130,100
| -54% | -$17.5M |
|
37
Cartesian Therapeutics
RNAC
$263M
| $14.6M | 0.6% |
+853,205
| New | +$14.6M |
|
|
ARRY
38
DELISTED
Array Biopharma Inc
ARRY
| $14.5M | 0.6% |
1,650,000
| – | – |
|
|
AAC
39
DELISTED
AAC Holdings, Inc.
AAC
| $14.3M | 0.59% |
1,975,347
-214,502
| -10% | -$1.55M |
|
|
ONCE
40
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $14.1M | 0.58% |
283,000
-85,000
| -23% | -$4.24M |
|
|
FOMX
41
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $13.7M | 0.56% |
1,232,844
-74,214
| -6% | -$824K |
|
42
Glaukos
GKOS
$5.43B
| $13.5M | 0.56% |
393,228
-110,049
| -22% | -$3.77M |
|
|
KITE
43
DELISTED
Kite Pharma, Inc.
KITE
| $13.4M | 0.55% |
+297,902
| New | +$13.4M |
|
44
Wave Life Sciences
WVE
$1.25B
| $12.3M | 0.51% |
+472,124
| New | +$12.3M |
|
|
ADPT
45
DELISTED
Adeptus Health Inc.
ADPT
| $12.2M | 0.5% |
1,600,861
| – | – |
|
46
CytomX Therapeutics
CTMX
$355M
| $10.4M | 0.43% |
943,433
| – | – |
|
47
Ionis Pharmaceuticals
IONS
$9.65B
| $10.2M | 0.42% |
+214,095
| New | +$10.2M |
|
48
Aclaris Therapeutics
ACRS
$221M
| $10.2M | 0.42% |
375,000
+259,000
| +223% | +$7.03M |
|
|
IVTY
49
DELISTED
Invuity, Inc
IVTY
| $9.72M | 0.4% |
1,690,498
+407,900
| +32% | +$2.35M |
|
|
ALPN
50
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $8.36M | 0.34% |
3,732,412
| – | – |
|